HR Execs on the Move

ChromaDex

www.chromadex.com

 
ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex`s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product, Tru Niagen® — available at www.truniagen.com and through partnerships with global retailers and distributors.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.chromadex.com
  • 10900 Wilshire Boulevard Suite 600
    Los Angeles, CA USA 90024
  • Phone: 310.388.6706

Executives

Name Title Contact Details
Brianna Gerber
Chief Financial Officer Profile
Jenny Robles
Director, People Matter(s) Profile
Aron Erickson
Vice President of R&D Profile
Yasmeen Nkrumah-Elie
Global Director of R&D for External Research Profile
Philip Redpath
Director, R&D Profile

Similar Companies

Psymed Inc

Psymed Inc is a Valley Forge, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

24 Hour Emergency Room

24 Hour Emergency Room is a Tomball, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

EG Life Sciences

EG Life Sciences is a hybrid professional Life Sciences consulting services firm that provides Pharmaceutical, Biotechnology, and Medical device companies with the resources they need to meet the unique challenges of FDA regulated industries.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.

University of Connecticut Health

UConn Health is a vibrant, integrated academic medical center that is entering an era of unprecedented growth in all three areas of its mission: academics, research, and clinical care. UConn Health is at the center of Bioscience Connecticut, a bold plan introduced by Connecticut Governor Dannel P. Malloy and approved by the Connecticut General Assembly in 2011. The plan will strengthen Connecticut`s position as a national and global leader for bioscience innovation and improve access to quality health care for Connecticut citizens for generations to come. Based in Farmington, Connecticut – a popular suburb of the state`s capitol of Hartford – UConn Health is home to the School of Medicine, School of Dental Medicine, John Dempsey Hospital, UConn Medical Group, UConn Health Partners, University Dentists and a thriving research enterprise. With approximately 5,000 employees, UConn Health is a major economic driver in the region, generating nearly $1 billion annually in gross state product. It is closely linked with the University of Connecticut`s main campus in Storrs through multiple, cross-campus academic projects.